Clinical Supply Packaging Resources
-
Is Your Clinical Supply Strategy Ready For EU CTR?
3/3/2022
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
Global Reach, Biotech Speed: Clinical Packaging, Labeling That Delivers
2/3/2026
By integrating scalable operations, reliable supply chains, and deep regulatory expertise, biotech companies can eliminate bottlenecks, improve efficiency, and accelerate trial execution.
-
Precision and Compliance in Pharmaceutical Packaging
1/26/2026
Reliable, compliant packaging preserves product integrity, supports regulatory readiness, and lowers risk. Careful components and controlled processes keep complex therapies protected.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
12/2/2022
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
Expertise And Transparency Drive A Distinct Development Journey
1/26/2026
Coordinated expertise, real‑time visibility, and clear communication support smoother development, manufacturing, and clinical supply. Strong alignment improves predictability and lowers risk.
-
Outsourcing Your Highly Potent Oncology Drug Product
4/6/2023
Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
The Dual Sourcing Approach
11/17/2022
Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
Advantages Of Robotic Aseptic Processing
10/6/2023
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
Key Considerations For Selecting Fill/Finish Manufacturing Technologies
Obtaining information and proactively mapping out your fill/finish strategy early can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.
-
Highly Potent, Perfectly Packaged
1/12/2023
Experts explore a project to add a contained manufacturing facility and potent packaging suite by discussing the attention to technical detail required to exceed the required high standards and regulatory controls.